Jordi Rello Condomines Clinical and epidemiologic research in pneumonia & Sepsis CIBERES Network- Node 18 Institutions of which they are part Head of group Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Jordi Rello Condomines LinkedIn Twitter Orcid Email Institutions of which they are part Head of group Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS) Vall Hebron Institut de Recerca Clinical and epidemiologic research in pneumonia & Sepsis CIBERES Network- Node 18
ORCID: 0000 0003 0676 6210 H-Index 118. google Scholar (accessed sept 14th, 2021) 50495 citations (4353 in 2020) Web of Science P-2402-2019
Research lines Severe Acute Respiratory Infections (SARI) To focus on the most prevalent aspects of SARI: Pneumococcal CAP, Viral VAP, Pseudomonas VAP, & MRSA VAP IP: Jordi Rello Condomines Projects Clinical Research and Epidemiology in Pneumonia & Sepsis (CRIPS) IP: Jordi Rello Condomines Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2017SGR01671 Duration: 01/01/2017 - 31/12/2020 Sol·licitud per estada a la University of Liverpool per al projecte "Pharmacokinetic Modelling for the individualisation of Antimicrobial Therapy in the Critically Ill" IP: Jordi Rello Condomines Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 6000 Reference: M_AES16/00012 Duration: 01/10/2016 - 31/12/2016 Clinical Research / Innovation in Pneumonia & Sepsis (CRIPS) (GRC) IP: Jordi Rello Condomines Collaborators: Candido Diaz Lagares, Yolanda Peña Lopez, Jordi Riera del Brío, Teresa Pont Castellana Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 28800 Reference: 2014 SGR 278 Duration: 01/01/2014 - 31/12/2016 Evaluación Prospectiva de la Pro-Calictonina y Pro-Adrenomedullina como Biomarcadores de Infección en Pacientes con Traqueobronquitis Asociada a la Ventilación Mecánica (BioVAT). IP: Jordi Rello Condomines Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 53732 Reference: CM14/00212 Duration: 01/01/2015 - 31/12/2016 Pagination Current page 1 Page 2 Page 3 Next page › Last page »
